Menu
GeneBe

11-47351294-G-C

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000256.3(MYBPC3):c.237C>G(p.Tyr79Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. Y79Y) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: not found (cov: 32)

Consequence

MYBPC3
NM_000256.3 stop_gained

Scores

2
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: -1.32
Variant links:
Genes affected
MYBPC3 (HGNC:7551): (myosin binding protein C3) MYBPC3 encodes the cardiac isoform of myosin-binding protein C. Myosin-binding protein C is a myosin-associated protein found in the cross-bridge-bearing zone (C region) of A bands in striated muscle. MYBPC3 is expressed exclusively in heart muscle and is a key regulator of cardiac contraction. Mutations in this gene are a frequent cause of familial hypertrophic cardiomyopathy. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-47351294-G-C is Pathogenic according to our data. Variant chr11-47351294-G-C is described in ClinVar as [Pathogenic]. Clinvar id is 181132.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-47351294-G-C is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYBPC3NM_000256.3 linkuse as main transcriptc.237C>G p.Tyr79Ter stop_gained 2/35 ENST00000545968.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYBPC3ENST00000545968.6 linkuse as main transcriptc.237C>G p.Tyr79Ter stop_gained 2/355 NM_000256.3 P4Q14896-1
MYBPC3ENST00000399249.6 linkuse as main transcriptc.237C>G p.Tyr79Ter stop_gained 2/345 A2
MYBPC3ENST00000544791.1 linkuse as main transcriptc.237C>G p.Tyr79Ter stop_gained, NMD_transcript_variant 2/275

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
36
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hypertrophic cardiomyopathy Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingAll of Us Research Program, National Institutes of HealthNov 02, 2023This variant changes 1 nucleotide in exon 2 of the MYBPC3 gene, creating a premature translation stop signal. This variant is expected to result in an absent or non-functional protein product. This variant has been reported in more than five unrelated individuals affected with hypertrophic cardiomyopathy (PMID: 17394878, 20624503, 20800588, 21896538, 24111713, 28138913, 28640247, 28971120, 32841044, 17394878, 21896538, 28138913). It has been shown that this variant segregates with disease in multiple affected individuals in one family (PMID: 17394878, 21896538, 28138913). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Different variants causing the same premature translation stop signal (c.237C>A p.Tyr79X and c.236dupA p.Tyr79X), are also known to be disease-causing (ClinVar variation ID: 407333 and 372710). Loss of MYBPC3 function is a known mechanism of disease (clinicalgenome.org). Based on the available evidence, this variant is classified as Pathogenic. -
Pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJul 01, 2015The p.Tyr79X variant in MYBPC3 has been reported in 1 Caucasian individual with HCM, segregated with disease in 3 affected relatives (including 1 obligate carri er), and was absent from 200 ethnically matched controls (Garcia-Pavia 2007, Gar cia-Pavia 2011). It has also been detected by another clinical testing laborato ry and is noted in the ClinVar database (http://www.ncbi.nlm.nih.gov/clinvar/var iation/181132). Data from large population studies is insufficient to assess the frequency of this variant. This nonsense variant leads to a premature terminati on codon at position 79, which is predicted to lead to a truncated or absent pro tein. Heterozygous loss of function of the MYBPC3 gene is an established disease mechanism in individuals with HCM. In summary, this variant meets our criteria to be classified as pathogenic for HCM in an autosomal dominant manner (http://w ww.partners.org/personalizedmedicine/LMM) based on the predicted impact of the v ariant. -
not provided Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingGeneDxOct 01, 2019Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 25525159, 17394878, 24111713, 21896538, 28971120, 20624503, 28640247) -
Hypertrophic cardiomyopathy 4 Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testing3billionSep 01, 2022The variant is not observed in the gnomAD v2.1.1 dataset. Stop-gained (nonsense) is predicted to result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000181132 / PMID: 17394878). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Uncertain
-0.050
Cadd
Benign
14
Dann
Benign
0.97
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.15
N
MutationTaster
Benign
1.0
A;A;A
Vest4
0.89
GERP RS
-6.5

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs730880698; hg19: chr11-47372845; API